Saint Louis University Hospital is a 356-bed non-profit, research and academic medical center located in St. Louis, Missouri, providing tertiary care for the east Missouri region. The medical center is a part of the SSM Health System and is affiliated with the Saint Louis University School of Medicine.

There are 356 beds in Saint Louis University Hospital.

During the past decade, Saint Louis University Hospital conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 68 clinical trials were completed, i.e. on average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 29 clinical trials were completed. i.e. 290% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Louis University Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "St. Louis University" with 10 trials sponsored, "Point Biomedical" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Louis University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Saint Louis University Hospital" are "Coronary Artery Disease" (9 trials), "Cervical Adenocarcinoma" (4 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (4 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (4 trials). Many other conditions were trialed in "Saint Louis University Hospital" in a lesser frequency.

Most popular intervention types in "Saint Louis University Hospital" are "Drug" (88 trials), "Other" (40 trials), "Biological" (35 trials), "Device" (17 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Bevacizumab" (14 trials), "Paclitaxel" (12 trials), "Placebo" (12 trials) and "Quality-of-Life Assessment" (11 trials). Other intervention names were less common.

The vast majority of trials in "Saint Louis University Hospital" are 119 trials for "All" genders, 18 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Louis University Hospital". undefined are not yet recruiting, 14 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Saint Louis University Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Louis University Hospital, 4 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".